Cardiovascular - November 2014 Archives

ROCHESTER, Minn. —The American Heart Association (AHA) awarded the 2014 Basic Research Prize to Andre Terzic, M.D., Ph.D., of Mayo Clinic. The award, presented at the annual meeting of the American Heart Association in Chicago, recognizes outstanding contributions to the advancement of cardiovascular science. Dr. Terzic was commended for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular diseases. “In the year when we celebrate the 100th anniversary of the Division of Cardiovascular Diseases at Mayo Clinic, we are particularly proud that one of our own has been recognized with such a prestigious national award,” says Charanjit Rihal, M.D., chair of Mayo's Division of Cardiovascular Diseases. “Dr. Terzic has truly advanced the frontiers of medical science. As a pioneer in cardiac regenerative medicine, he and his team have been at the vanguard of health care.” “As we look into the future, the pandemic of cardiovascular disease will mandate new solutions, indeed disruptive innovations, to address the unmet needs of patients and populations across the globe,” Dr. Terzic said when he accepted the prize. “The unison of fundamental discovery with clinical translation — and ultimately application to populations — will provide a guiding principle for generations to come.” MEDIA CONTACT: Jennifer Schutz, Mayo Clinic Public Affairs, 507-284-5005,newsbureau@mayo.edu

CHICAGO — Patients with active asthma  — such as any use of asthma medications, and unscheduled office or emergency visits for asthma — are at a twofold risk of having a heart attack, according to Mayo Clinic research presented at the American Heart Association’s Scientific Sessions 2014. Researchers compared 543 patients who had heart attacks with 543 non-heart attack patients of the same age and gender. These patients were treated at health care facilities in Rochester, Minnesota, between 2002 and 2006. The average age of patients was 67 years old, and 44 percent were women. Within the heart attack patient group, 81 patients had asthma, 44 of those with active asthma. After controlling for traditional heart attack risk factors such as age, obesity, high blood pressure, smoking, diabetes and high cholesterol, a history of coronary heart disease, and conditions such as chronic obstructive pulmonary disease, results showed that patients with inactive asthma were not at an increased risk of heart attack, but those with active asthma were at a 70 percent risk, says Young Juhn, M.D., senior author and Mayo Clinic pediatric and adolescent physician and clinical epidemiologist.

On the next Mayo Clinic Radio, Saturday, November 8 at 9 a.m. CT, we’ll discuss the latest news from the Mayo Clinic Cardiology + Structural Heart Disease: Innovation Summit 2014. Replacing or repairing someone's heart valve through a blood vessel is a modern-day marvel. We'll find out how they do it. Plus, regenerating damaged heart tissue is a new frontier in cardiac care. Repair, replace and regenerate — how the newest innovations can save your heart.  Experts Charles Bruce, M.D., and Rakesh Suri, M.D., will be with us ... hope you join us, too! Myth or Fact: Stem cell therapy for heart disease is an alternative to bypass surgery and/or stents. Follow #MayoClinicRadio and tweet your questions. To listen to the program on Saturday, click here. Mayo Clinic Radio is available on iHeart Radio. Listen to this week’s Medical News Headlines: News Segment November 8, 2014 (right click MP3)

ROCHESTER and MINNEAPOLIS, Minn. — The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $2.5 million to four teams of researchers to support scientific infrastructure used in collaborations between existing researchers at the University of Minnesota and Mayo Clinic. The funding must be used for equipment, software or other technology essential to specific research projects and must be mutually available to the project participants at both institutions. This year’s awards will help investigators target topics ranging from heart disease and cancer to drug development and the microbiome, all key focus areas of research in Minnesota.

  Miss the show? Here's the podcast! Mayo Clinic Radio Full Show 11-8-2014 44min mp3   On Mayo Clinic Radio, Saturday, November 8 at ...